尿流動態デバイスの世界市場：洞察、競合情勢、市場予測：2030年

世界の尿流動態デバイスの市場規模は、2023年に4億335万米ドルとなりました。同市場は、2024年から2030年までの予測期間中に6.03％のCAGRで拡大し、2030年には5億7,316万米ドルに達すると予測されています。尿流動態デバイス市場は、腎臓疾患の有病率の上昇、膀胱がんの有病率の上昇、ウロダイナミック装置の技術進歩などにより、2024年から2030年までの予測期間中に尿流動態デバイス市場の成長に寄与しています。

腎臓疾患の有病率の上昇は、尿流動態デバイス市場の主要な促進要因です。

例えば、2020年の世界腎臓デー組織によると、腎臓病は世界中の約8億5,000万人が罹患している非伝染性疾患です。同じ情報源によると、成人の約10人に1人が慢性腎臓病に罹患していることが観察されており、2040年までに世界的に生命喪失の5番目に多い原因になると予測されています。

全米腎臓財団（National Kidney Foundation）2022年の発表によると、2020年には世界人口の約10％が慢性腎臓病に罹患しており、手頃な価格の治療法を十分に利用できず、毎年数百万人が亡くなっています。同資料によれば、2020年には約200万人以上が透析や腎臓移植の治療を受けているが、この数字は生存のために治療を必要とする人々の10％に過ぎません。

米国疾病予防管理センター（Centers for Disease Control and Prevention 2022）によると、2020年には、米国の7人に1人以上、つまり15％にあたる3,700万人が慢性腎臓病を患っていると推定されています。

Kidney Care UKによると、2020年には英国で約300万人が慢性腎臓病を患っています。また、同出典によると、英国では毎年約40～45,000人がCKDが原因で早期死亡しています。

したがって、腎臓疾患の有病率の上昇により、尿流動態デバイスの需要が増加し、尿流動態デバイス市場の成長に拍車がかかるとみられています。

当レポートでは、世界の尿流動態デバイス市場について調査し、市場の概要とともに、製品タイプ別、エンドユーザー別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 尿流動態デバイス市場レポートのイントロダクション

第2章 尿流動態デバイス市場のエグゼクティブサマリー

第3章 規制と特許の分析

第4章 尿流動態デバイス市場の主な要因分析

• 尿流動態デバイス市場の促進要因
• 尿流動態デバイス市場の抑制要因と課題
• 尿流動態デバイス市場の機会

第5章 尿流動態デバイス市場におけるポーターのファイブフォース分析

第6章 尿流動態デバイス市場に対するCOVID-19の影響分析

第7章 尿流動態デバイス市場の概要

• 製品タイプ別
• エンドユーザー別
• 地域別

第8章 尿流動態デバイス市場の世界企業シェア分析-主要3～5社

第9章 尿流動態デバイス市場の企業と製品プロファイル

• B Braun Meslungen AG
• BestMedical
• MINZE HEALTH
• Santron Meditronic.
• Potent Medical
• Laborie
• MEDKONSULT medical technology s.r.o.
• The Prometheus Group®
• HCItalia srl
• DeltaMed
• Aymed Medical Technology
• EV.SERVICE ITALIA
• tic Medizintechnik GmbH & Co. KG
• Creo Medical Ltd
• Stericom Ltd.
• Amecath Medical Technologies
• Cook
• Well Lead Medical Co., Ltd
• MEDICA S.P.A

第10章 KOL の見解

第11章 プロジェクトのアプローチ

第12章 DelveInsightについて

第13章 免責事項とお問い合わせ

List of Tables

• Table 1: Competitive Analysis
• Table 2: COVID-19 Impact Analysis
• Table 3: Urodynamic Devices Market in Global (2021-2030)
• Table 4: Urodynamic Devices Market in Global by Product Type (2021-2030)
• Table 5: Urodynamic Devices Market in Global by End User (2021-2030)
• Table 6: Urodynamic Devices Market in Global by Geography (2021-2030)
• Table 7: Urodynamic Devices Market in North America (2021-2030)
• Table 8: Urodynamic Devices Market in North America by Country (2021-2030)
• Table 9: Urodynamic Devices Market in the US (2021-2030)
• Table 10: Urodynamic Devices Market in Canada (2021-2030)
• Table 11: Urodynamic Devices Market in Mexico (2021-2030)
• Table 12: Urodynamic Devices Market in Europe (2021-2030)
• Table 13: Urodynamic Devices Market in Europe by Country (2021-2030)
• Table 14: Urodynamic Devices Market in France (2021-2030)
• Table 15: Urodynamic Devices Market in Germany (2021-2030)
• Table 16: Urodynamic Devices Market in the United Kingdom (2021-2030)
• Table 17: Urodynamic Devices Market in Italy (2021-2030)
• Table 18: Urodynamic Devices Market in Spain (2021-2030)
• Table 19: Urodynamic Devices Market in Russia (2021-2030)
• Table 20: Urodynamic Devices Market in Rest of Europe (2021-2030)
• Table 21: Urodynamic Devices Market in APAC (2021-2030)
• Table 22: Urodynamic Devices Market in APAC by Country (2021-2030)
• Table 23: Urodynamic Devices Market in China (2021-2030)
• Table 24: Urodynamic Devices Market in Japan (2021-2030)
• Table 25: Urodynamic Devices Market in India (2021-2030)
• Table 26: Urodynamic Devices Market in Australia (2021-2030)
• Table 27: Urodynamic Devices Market in South Korea (2021-2030)
• Table 28: Urodynamic Devices Market in Rest of APAC (2021-2030)
• Table 29: Urodynamic Devices Market in Rest of World (2021-2030)
• Table 30: Urodynamic Devices Market in RoW by Region (2021-2030)
• Table 31: Urodynamic Devices Market in Middle East (2021-2030)
• Table 32: Urodynamic Devices Market in Africa (2021-2030)
• Table 33: Urodynamic Devices Market in South America (2021-2030)

List of Figures

• Figure 1: Competitive Analysis
• Figure 2: COVID-19 Impact Analysis
• Figure 3: Urodynamic Devices Market in Global (2021-2030)
• Figure 4: Urodynamic Devices Market in Global by Product Type (2021-2030)
• Figure 5: Urodynamic Devices Market in Global by End User (2021-2030)
• Figure 6: Urodynamic Devices Market in Global by Geography (2021-2030)
• Figure 7: Urodynamic Devices Market in North America (2021-2030)
• Figure 8: Urodynamic Devices Market in North America by Country (2021-2030)
• Figure 9: Urodynamic Devices Market in the US (2021-2030)
• Figure 10: Urodynamic Devices Market in Canada (2021-2030)
• Figure 11: Urodynamic Devices Market in Mexico (2021-2030)
• Figure 12: Urodynamic Devices Market in Europe (2021-2030)
• Figure 13: Urodynamic Devices Market in Europe by Country (2021-2030)
• Figure 14: Urodynamic Devices Market in France (2021-2030)
• Figure 15: Urodynamic Devices Market in Germany (2021-2030)
• Figure 16: Urodynamic Devices Market in the United Kingdom (2021-2030)
• Figure 17: Urodynamic Devices Market in Italy (2021-2030)
• Figure 18: Urodynamic Devices Market in Spain (2021-2030)
• Figure 19: Urodynamic Devices Market in Russia (2021-2030)
• Figure 20: Urodynamic Devices Market in Rest of Europe (2021-2030)
• Figure 21: Urodynamic Devices Market in APAC (2021-2030)
• Figure 22: Urodynamic Devices Market in APAC by Country (2021-2030)
• Figure 23: Urodynamic Devices Market in China (2021-2030)
• Figure 24: Urodynamic Devices Market in Japan (2021-2030)
• Figure 25: Urodynamic Devices Market in India (2021-2030)
• Figure 26: Urodynamic Devices Market in Australia (2021-2030)
• Figure 27: Urodynamic Devices Market in South Korea (2021-2030)
• Figure 28: Urodynamic Devices Market in Rest of APAC (2021-2030)
• Figure 29: Urodynamic Devices Market in Rest of World (2021-2030)
• Figure 30: Urodynamic Devices Market in RoW by Region (2021-2030)
• Figure 31: Urodynamic Devices Market in Middle East (2021-2030)
• Figure 32: Urodynamic Devices Market in Africa (2021-2030)
• Figure 33: Urodynamic Devices Market in South America (2021-2030)
• Figure 34: Market Drivers
• Figure 35: Market Barriers
• Figure 36: Marker Opportunities
• Figure 37: PORTER'S Five Force Analysis

Urodynamic Devices Market By Product Type (Uroflowmetry Equipment, Electromyograph, Urodynamic Systems, Urodynamic Catheters, Urodynamic Pumps And Transducer Sets, Others), By End-User (Hospitals And Urology Clinics, Ambulatory Surgery Centers, Others), by geography is expected to grow at a steady CAGR forecast till 2030 owing to rising prevalence of kidney disorders, increasing prevalence of bladder cancers

Global Urodynamic Devices Market was valued at USD 403.35 Million in 2023, growing at a CAGR of 6.03% during the forecast period from 2024 to 2030 to reach USD 573. 16 Million by 2030. The Urodynamic Devices market is witnessing positive growth owing to the rising prevalence of kidney disorders, increasing prevalence of bladder cancers, technological advancements in Urodynamic Equipment, thereby contributing to the growth of the Urodynamic Devices market during the forecast period from 2024-2030.

Urodynamic Devices Market Dynamics:

The rising prevalence of kidney disorders is the key driving factor for the Urodynamic Devices market.

For instance, as per the World Kidney Day organization in 2020, kidney disease is a non-communicable disease affecting about 850 million people across the world. as per the same source, about one in ten adults are observed to be suffering from chronic kidney disease which is projected to become the fifth most common cause of life loss globally by the year 2040.

As per the National Kidney Foundation 2022, in 2020 about 10% of the population globally suffered from chronic kidney diseases and millions of people were dying every year as they did not have enough access to affordable treatments. As per the same source, about over 2 million people had received treatment with dialysis or kidney transplant in the year 2020 but this number represents only 10% of the people requiring treatment to stay alive.

According to the Centers for Disease Control and Prevention 2022, more than one in seven, that is 15% of the US people or 37 million people were estimated to be have suffered from chronic kidney disorders in the year 2020.

As per the Kidney Care UK in 2020, around 3 million people in the United Kingdom were suffering from chronic kidney diseases. Also as per the same source, there are about 40-45,000 premature deaths in the UK every year due to CKD.

Therefore, due to the rising prevalence of kidney disorders, there will be an increase in the demand for urodynamic devices, thereby fueling the market growth for Urodynamic Devices.

However, the high cost of the urodynamic devices and tests and complications associated with urodynamic catheters such as pain, patient anxiety, and injury may be certain limiting factors of the Urodynamic Devices market growth.

The unprecedented COVID-19 outbreak had a profound impact on the market for urodynamic devices. Owing to the lockdown restrictions posed during the COVID-19 pandemic, there were reduced patients visits, and all other surgical/diagnostic procedures were temporarily paused, giving more attention to the COVID-19 inflicted patients. However, as a result of relaxation observed in the COVID-19 lockdown and the approvals and launches in the urodynamic devices arena, there had been normalcy attained in the growth of the urodynamic devices market.

Urodynamic Devices Market Segment Analysis:

Urodynamic Devices Market By Product Type (Uroflowmetry Equipment, Electromyograph, Urodynamic Systems, Urodynamic Catheters, Urodynamic Pumps and Transducer Sets, Others), By End-User (Hospitals and Urology Clinics, Ambulatory Surgery Centers, Others), and By Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the Product Type segment of the Urodynamic Devices market, Electromyograph are estimated to hold a higher share in the Urodynamic Devices market during the forecast period (2024-2030). This can be attributed to the specific features associated with these devices.

The demand for electromyography devices will improve owing to the rising prevalence of kidney disorders and bladder cancers globally, the approval and launch of electromyography devices, and the increased research and development on electromyography devices.

For instance, as per the World Bladder Cancer Patient Coalition in the year 2020, about 573,278 people are suffering from bladder cancer globally. As per the same source, bladder cancer is considered the tenth most commonly diagnosed cancer in the world.

As per the National Institute of Health in the year 2020, the rate of new cases of bladder cancer was 19.7 per 100,000 men and women per year. As per the same source, approximately 2.4 percent of men and women will be diagnosed with bladder cancer at some point during their lifetime, based on 2016-2018 data.

Furthermore, according to the International Society of Nephrology 2022, in the year 2020 more than 850 million people were suffering from chronic kidney disorders.

Hence, all the aforementioned factors will contribute to the growth of electromyograph devices in Urodynamic Devices market.

North America is expected to dominate the overall Urodynamic Devices Market:

Among all the regions, North America is expected to account for the largest share in the Global Urodynamic Devices market. The rising prevalence of renal disorders and urinary bladder cancers, growing products approvals, and launches along favorable reimbursement policies are the key factor contributing to the Urodynamic Devices market in the country.

According to the National Institute of Health in the year 2020, 1 in 7 adults in the United States was suffering from chronic kidney disease. This accounts for a total of 37 million Americans.

Also, as per the Centers for Disease Control and Prevention 2022, in the year 2020 chronic kidney disorders are more common in people aged 65 years or older (38%) than in people aged 45-64 years (12%) or 18-44 years (6%) for the United States.

As per the American Journal of Kidney Diseases 2020, End-Stage Renal Disease (ESRD) prevalence in the United States remains one of the highest in the world at 2,242 cases per million population in 2018.

As per the American Cancer Society's estimates for bladder cancer in the United States in the year 2020, about 83,730 new cases of bladder cancer were diagnosed (about 64,280 in men and 19,450 in women).

Thus, all the above-mentioned factors are anticipated to propel the market for Urodynamic Devices in the United States region.

Urodynamic Devices Market Key Players:

Some of the key market players operating in the Urodynamic Devices market include B Braun Meslungen AG, BestMedical, MINZE HEALTH, Santron Meditronic., Potent Medical, Laborie, MEDKONSULT medical technology s.r.o., The Prometheus Group®, HCItalia srl, DeltaMed, MEDICA S.P.A, Aymed Medical Technology, EV.SERVICE ITALIA, tic Medizintechnik GmbH & Co. KG, Creo Medical Ltd, Stericom Ltd., Amecath Medical Technologies, Cook, Well Lead Medical Co., Ltd, and others.

Recent Developmental Activities in the Urodynamic Devices Market:

In March 2022, A video urodynamic lab was inaugurated at the Delhi government-run Lok Nayak Hospital by Health Minister. The lab is capable of taking real-time pictures of the urinary tract and bladder, which also provides immediate biofeedback.

Key Takeaways from the Urodynamic Devices Market Report Study

• Market size analysis for current Urodynamic Devices market size (2023), and market forecast for 5 years (2024-2030)
• The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the Urodynamic Devices market.
• Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years
• Key companies dominating the global Urodynamic Devices market.
• Various opportunities available for the other competitor in the Urodynamic Devices market space.
• What are the top performing segments in 2023? How these segments will perform in 2030.
• Which is the top-performing regions and countries in the current Urodynamic Devices market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for Urodynamic Devices market growth in the coming future?

Target Audience who can be benefited from this Urodynamic Devices Market Report Study

• Urodynamic Devices products providers
• Research organizations and consulting companies
• Urodynamic Devices-related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and Traders dealing in Urodynamic Devices
• Various End-users who want to know more about the Urodynamic Devices market and latest technological developments in the Urodynamic Devices market.

Frequently Asked Questions for the Urodynamic Devices Market:

1. What are Urodynamic Devices?

Urodynamic Devices are created to investigate the function of the urinary tract by taking physical measurements of bladder pressure and flow rates.

2. What is the market for Global Urodynamic Devices?

Global Urodynamic Devices Market was valued at USD 403.35 Million in 2023, growing at a CAGR of 6.03% during the forecast period from 2024 to 2030 to reach USD 573. 16 Million by 2030.

3. What are the drivers for the Global Urodynamic Devices Market?

The Urodynamic Devices market is witnessing positive market growth owing to the rising prevalence of kidney disorders, increasing prevalence of bladder cancers, technological advancements in Urodynamic Equipment, thereby contributing to the growth of the Urodynamic Devices market during the forecast period from 2024-2030

4. Who are the key players operating in the Global Urodynamic Devices Market?

Some of the key market players operating in the Urodynamic Devices market include B Braun Meslungen AG, BestMedical, MINZE HEALTH, Santron Meditronic., Potent Medical, Laborie, MEDKONSULT medical technology s.r.o., The Prometheus Group®, HCItalia srl, DeltaMed, MEDICA S.P.A, Aymed Medical Technology, EV.SERVICE ITALIA, tic Medizintechnik GmbH & Co. KG, Creo Medical Ltd, Stericom Ltd., Amecath Medical Technologies, Cook, Well Lead Medical Co., Ltd, and others.

5. Which region has the highest share in Urodynamic Devices Market?

North America is expected to hold the highest share in the revenue in the Urodynamic Devices market during the forecast period. The rising prevalence of renal disorders and urinary bladder cancers, growing products approvals, and launches along with favorable reimbursement policies are the key factor contributing to the Urodynamic Devices market in the country are expected to aid in the growth of the North America Urodynamic Devices Market.

Table of Contents

1.Urodynamic Devices Market Report Introduction

2.Urodynamic Devices Market Executive Summary

• 2.1. Scope of the Study
• 2.2. Market at Glance
• 2.3. Competitive Assessment
• 2.4. Financial Benchmarking

3. Regulatory and Patent Analysis

• 3.1. The United States
• 3.2. Europe
• 3.3. Japan
• 3.4. China

4. Urodynamic Devices Market Key Factors Analysis

• 4.1. Urodynamic Devices Market Drivers
  • 4.1.1. Rising Prevalence of Kidney Disorders
  • 4.1.2. Increasing Prevalence of Bladder Cancers
  • 4.1.3. Technological Advancements in Urodynamic Equipment
• 4.2. Urodynamic Devices Market Restraints and Challenges
  • 4.2.1. High Cost of the urodynamic devices and tests
  • 4.2.2. Complications associated with urodynamic catheters such as pain, patient anxiety, and injury
• 4.3. Urodynamic Devices Market Opportunities
  • 4.3.1. Growing cases of urinary incontinence globally
  • 4.3.2. A shift from invasive to non-invasive forms of urodynamic testing procedures

5. Urodynamic Devices Market Porter's Five Forces Analysis

• 5.1. Bargaining Power of Suppliers
• 5.2. Bargaining Power of Consumers
• 5.3. Threat of New Entrants
• 5.4. Threat of Substitutes
• 5.5. Competitive Rivalry

6. COVID-19 Impact Analysis on Urodynamic Devices Market

7. Urodynamic Devices Market Layout

• 7.1. By Product Type
  • 7.1.1. Uroflowmetry Equipment
  • 7.1.2. Electromyograph
  • 7.1.3. Urodynamic Systems
  • 7.1.4. Urodynamic Catheters
  • 7.1.5. Urodynamic Pumps and Transducer Sets
  • 7.1.6. Others
• 7.2. By End-User
  • 7.2.1. Hospitals and Urology Clinics
  • 7.2.2. Ambulatory Centres
  • 7.2.3. Others
• 7.3. By Geography
  • 7.3.1. North America
    • 7.3.1.1. North America Urodynamic Devices Market, by Country
    • 7.3.1.1.1. United States
    • 7.3.1.1.2. Canada
    • 7.3.1.1.3. Mexico
  • 7.3.2. Europe
    • 7.3.2.1. Europe Urodynamic Devices Market, by Country
    • 7.3.2.1.1. France
    • 7.3.2.1.2. Germany
    • 7.3.2.1.3. United Kingdom
    • 7.3.2.1.4. Italy
    • 7.3.2.1.5. Spain
    • 7.3.2.1.6. Russia
    • 7.3.2.1.7. Rest of Europe
  • 7.3.3. Asia-Pacific
    • 7.3.3.1. Asia-Pacific Urodynamic Devices Market, by Country
    • 7.3.3.1.1. China
    • 7.3.3.1.2. Japan
    • 7.3.3.1.3. India
    • 7.3.3.1.4. Australia
    • 7.3.3.1.5. South Korea
    • 7.3.3.1.6. Rest of Asia Pacific
  • 7.3.4. Rest of the World (RoW)
    • 7.3.4.1. RoW Urodynamic Devices Market, by Country
    • 7.3.4.1.1. Middle East
    • 7.3.4.1.2. Africa
    • 7.3.4.1.3. South America

8. Urodynamic Devices Market Global Company Share Analysis - Key 3-5 Companies

9. Urodynamic Devices Market Company and Product Profiles

• 9.1. B Braun Meslungen AG
  • 9.1.1. Company Overview
  • 9.1.2. Company Snapshot
  • 9.1.3. Financial Overview
  • 9.1.4. Product Listing
  • 9.1.5. Entropy
• 9.2. BestMedical
  • 9.2.1. Company Overview
  • 9.2.2. Company Snapshot
  • 9.2.3. Financial Overview
  • 9.2.4. Product Listing
  • 9.2.5. Entropy
• 9.3. MINZE HEALTH
  • 9.3.1. Company Overview
  • 9.3.2. Company Snapshot
  • 9.3.3. Financial Overview
  • 9.3.4. Product Listing
  • 9.3.5. Entropy
• 9.4. Santron Meditronic.
  • 9.4.1. Company Overview
  • 9.4.2. Company Snapshot
  • 9.4.3. Financial Overview
  • 9.4.4. Product Listing
  • 9.4.5. Entropy
• 9.5. Potent Medical
  • 9.5.1. Company Overview
  • 9.5.2. Company Snapshot
  • 9.5.3. Financial Overview
  • 9.5.4. Product Listing
  • 9.5.5. Entropy
• 9.6. Laborie
  • 9.6.1. Company Overview
  • 9.6.2. Company Snapshot
  • 9.6.3. Financial Overview
  • 9.6.4. Product Listing
  • 9.6.5. Entropy
• 9.7. MEDKONSULT medical technology s.r.o.
  • 9.7.1. Company Overview
  • 9.7.2. Company Snapshot
  • 9.7.3. Financial Overview
  • 9.7.4. Product Listing
  • 9.7.5. Entropy
• 9.8. The Prometheus Group®
  • 9.8.1. Company Overview
  • 9.8.2. Company Snapshot
  • 9.8.3. Financial Overview
  • 9.8.4. Product Listing
  • 9.8.5. Entropy
• 9.9. HCItalia srl
  • 9.9.1. Company Overview
  • 9.9.2. Company Snapshot
  • 9.9.3. Financial Overview
  • 9.9.4. Product Listing
  • 9.9.5. Entropy
• 9.10. DeltaMed
  • 9.10.1. Company Overview
  • 9.10.2. Company Snapshot
  • 9.10.3. Financial Overview
  • 9.10.4. Product Listing
  • 9.10.5. Entropy
• 9.11. Aymed Medical Technology
  • 9.11.1. Company Overview
  • 9.11.2. Company Snapshot
  • 9.11.3. Financial Overview
  • 9.11.4. Product Listing
  • 9.11.5. Entropy
• 9.12. EV.SERVICE ITALIA
  • 9.12.1. Company Overview
  • 9.12.2. Company Snapshot
  • 9.12.3. Financial Overview
  • 9.12.4. Product Listing
  • 9.12.5. Entropy
• 9.13. tic Medizintechnik GmbH & Co. KG
  • 9.13.1. Company Overview
  • 9.13.2. Company Snapshot
  • 9.13.3. Financial Overview
  • 9.13.4. Product Listing
  • 9.13.5. Entropy
• 9.14. Creo Medical Ltd
  • 9.14.1. Company Overview
  • 9.14.2. Company Snapshot
  • 9.14.3. Financial Overview
  • 9.14.4. Product Listing
  • 9.14.5. Entropy
• 9.15. Stericom Ltd.
  • 9.15.1. Company Overview
  • 9.15.2. Company Snapshot
  • 9.15.3. Financial Overview
  • 9.15.4. Product Listing
  • 9.15.5. Entropy
• 9.16. Amecath Medical Technologies
  • 9.16.1. Company Overview
  • 9.16.2. Company Snapshot
  • 9.16.3. Financial Overview
  • 9.16.4. Product Listing
  • 9.16.5. Entropy
• 9.17. Cook
  • 9.17.1. Company Overview
  • 9.17.2. Company Snapshot
  • 9.17.3. Financial Overview
  • 9.17.4. Product Listing
  • 9.17.5. Entropy
• 9.18. Well Lead Medical Co., Ltd
  • 9.18.1. Company Overview
  • 9.18.2. Company Snapshot
  • 9.18.3. Financial Overview
  • 9.18.4. Product Listing
  • 9.18.5. Entropy
• 9.19. MEDICA S.P.A
  • 9.19.1. Company Overview
  • 9.19.2. Company Snapshot
  • 9.19.3. Financial Overview
  • 9.19.4. Product Listing
  • 9.19.5. Entropy

10. KOL Views

11. Project Approach

12. About DelveInsight

13. Disclaimer & Contact Us